AbbVie
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade AbbVie 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.
CEORobert A. Michael
CEORobert A. Michael
Employees55,000
Employees55,000
HeadquartersNorth Chicago, Illinois
HeadquartersNorth Chicago, Illinois
Founded2011
Founded2011
Employees55,000
Employees55,000
ABBV Key Statistics
Market cap355.82B
Market cap355.82B
Price-Earnings ratio94.53
Price-Earnings ratio94.53
Dividend yield3.26%
Dividend yield3.26%
Average volume5.38M
Average volume5.38M
High today$201.72
High today$201.72
Low today$199.22
Low today$199.22
Open price$199.74
Open price$199.74
Volume3.52M
Volume3.52M
52 Week high$218.66
52 Week high$218.66
52 Week low$163.81
52 Week low$163.81
ABBV News
Seeking Alpha 1d
AbbVie to invest $195M to build plant in IllinoisAbbVie (NYSE:ABBV) has revealed plans to invest $195M in its manufacturing facility located in North Chicago, Illinois, to boost the production of active pharma...
Seeking Alpha 4d
Insider trades: AbbVie, Coca Cola , Roblox among notable names this weekAbbVie (NYSE:ABBV), Blackstone (NYSE:BX) and Roblox (NYSE:RBLX) were some of the firms that witnessed insider transactions this week. Below is a list of purchas...
Seeking Alpha 6d
Genmab rises on late-stage trial win for AbbVie-partnered lymphoma therapyGenmab (GMAB) traded higher on Thursday after the Danish biotech, with its H1 2025 results, announced that its bispecific antibody epcoritamab, developed with A...
Analyst ratings
60%
of 30 ratingsBuy
60%
Hold
40%
Sell
0%
People also own
Based on the portfolios of people who own ABBV. This list is generated using Robinhood data, and it’s not a recommendation.